Author:
Bhosle Monali J,Kulkarni Amit,Feldman Steven R,Balkrishnan Rajesh
Abstract
Abstract
Psoriasis is one of the prevalent skin conditions in the United States. This chronic condition has a significant negative impact on patients' quality of life. Psoriasis has been linked to the depression and suicidal tendencies in the patients. The costs associated with decrements in quality of life, lost productivity, and work absenteeism may be enormous, increasing overall costs associated with the disease management. This review attempts to outline different quality of life measures available for psoriasis and describes their use in studies examining patient reported outcomes associated with pharmacological interventions for psoriasis. Factors associated with quality of life in psoriasis patients are described. It further describes physician's role in the psoriasis management to improve patients' overall well-being.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,General Medicine
Reference50 articles.
1. Raychaudhuri SP, Farber EM: The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 2001, 15: 16–17. 10.1046/j.1468-3083.2001.00192.x
2. Lebwohl M: Psoriasis. Lancet 2003, 361: 1197–1204. 10.1016/S0140-6736(03)12954-6
3. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T: Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004, 9: 136–9. 10.1046/j.1087-0024.2003.09102.x
4. Linden KG, Weinstein GD: Psoriasis: current perspectives with an emphasis on treatment. Am J Med 1999, 107: 595–605. 10.1016/S0002-9343(99)00284-3
5. Lewin Group: The Burden of Skin Diseases 2005. The Society for Investigative Dermatology and the American Academy of Dermatology Association 2005. [http://www.sidnet.org/]
Cited by
249 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献